NAD+ Report

Route and milligrams first, then the price

87 of the 230 NAD+ pages we opened published no price

The boards on this site are built from 143 pages that published a NAD+ price. They were not the only pages opened. 230 readings were taken across 122 sellers, and 87 of them produced nothing a price could be read off. That is the single most common outcome of opening a NAD+ product page, and it is invisible everywhere else on this site.

What the silence is made of

The 230 readings, by what came out of them

all 230 page readings

143 of 230 priced something
at least one figure a reader could decide, with its qualifier and its route attached
43 of 230 showed no dollar amount
the page rendered and simply does not put a number in front of a reader
23 of 230 money, not a NAD+ price
the page rendered and showed dollar amounts, but they belong to something else — a different treatment, a shipping line, a membership
21 of 230 did not render for us
a challenge screen, an empty shell, or a page that never finished loading — recorded as undetermined, never as a seller publishing nothing

Every page opened for this site, read September 2026. The bands partition the readings; each page falls in exactly one.

The last band is ours, not the seller’s, and it is the one worth being careful about. 21 readings came back with too little text to judge anything. That is recorded as undetermined rather than as “no price”, because a page we could not read is not a page with nothing on it. None of those 21 is counted anywhere on this site as a seller publishing nothing.

22 readings failed to render in total, not 21. The difference is a single page that failed on the first attempt and gave up a price on a slower re-read, so it sits in the first band above. Both numbers are printed because the smaller one alone would describe our success rate rather than the market.

19 of them were not about NAD+ at all

19 of the 87 silent readings never used the word NAD, in any form, anywhere in what a reader sees. These are pages a NAD+ link on the seller’s own site led to: category pages, redirects that landed somewhere else, and one address that returned a 404.

The 87 readings that produced no price, three ways
  1. Never mentioned NAD+ in visible text

    19 of 87

  2. Rendered, but carried no dollar amount

    43 of 87

  3. Did not render enough to judge

    21 of 87recorded as undetermined, never as “no price”

Computed over the 87 readings that produced no figure, out of 230 total. Read September 2026.

The one signal that predicted it in advance

Which page to open was decided before any of them was opened, from links the seller’s own site published. Where the only NAD+ link available looked like a blog post or an intake form rather than a product page, the reading was marked as a weak target at that point — a prediction, made in advance, that it probably would not carry a price.

It was right. 3 of the 19 weak targets produced a price. 140 of the 211 other readings did.

A prediction made before the page was opened, against what happened
  1. Blog- or intake-shaped addresses that priced something

    3 of 19

  2. Every other address that priced something

    140 of 211

The weak flag is set by the target-selection pass on any URL whose path looks like a blog post or an intake form. Computed over all 230 readings, September 2026.

Which sellers this leaves with nothing

A silent page is usually not a silent seller. 69 sellers had at least one reading that produced nothing, and 49 of them priced something on another page. Up to three NAD+ pages were read per seller — the distribution is 34 sellers had 1, 68 sellers had 2, 20 sellers had 3 — so a seller with one silent page usually had a second page that worked.

20 of 69

sellers with a silent page priced nothing on any page we read

30 of 136

sellers we set out to price published no figure we could use

106 of 136

sellers reached the roster the boards are built from

30 of the 136 sellers this research set out to price ended with no usable figure — which is why the boards carry 106 companies and not 136. Every one of those 30 was pursued further rather than dropped: the walk one click past a silent page is what happened next, and it is its own page because the answer is not the one you would expect.

What this does and does not show

This is not medical advice. Nobody here is a clinician, this site runs no clinical review, and none of it should be read as a recommendation to take or avoid anything. Decisions about NAD+ belong with a licensed clinician who has your history in front of them.

The other 15